Home » Topics » Regulatory

Regulatory
RSS

Retisert launched for chronic noninfectious uveitis

July 6, 2005

New approval for Topamax

July 5, 2005

Avelox approved for complicated skin and skin structure infections

July 1, 2005

BiDil approved for treatment of heart failure in black patients

June 28, 2005

Accelerated approval for Aptivus in HIV

June 23, 2005

Tygacil receives FDA approval

June 17, 2005

Enbrel approved to improve physical function in psoriatic arthritis

June 2, 2005

FDA approval for Naglazyme

June 2, 2005

New approval for Arixtra

May 31, 2005

Remicade approved for psoriatic arthritis

May 18, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...